Treatment of hypertensive complications in pregnancy

Current Pharmaceutical Design

Volumn 11, Issue 6, 2005, Pages 749-757

  Coppage, K H ^a   Sibai, B M ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Antihypertensive medications; Hypertension; Preeclampsia; Pregnancy; Treatment

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CLONIDINE; DIAZEPAM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FUROSEMIDE; GLUCONATE CALCIUM; GLYCERYL TRINITRATE; HYDRALAZINE; LABETALOL; LISINOPRIL; LIVER ENZYME; MAGNESIUM SULFATE; METHYLDOPA; NICARDIPINE; NIFEDIPINE; NITROPRUSSIDE SODIUM; PHENYTOIN; PINDOLOL; PLACEBO; RADIOISOTOPE; THIAZIDE DIURETIC AGENT; UNINDEXED DRUG; URIC ACID; VASODILATOR AGENT;

ACUTE DISEASE; ACUTE PANCREATITIS; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE; CLINICAL FEATURE; CLINICAL TRIAL; CONGENITAL MALFORMATION; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG ACTIVITY; DRUG CONTRAINDICATION; DRUG DOSE REGIMEN; DRUG HALF LIFE; DRUG INTOXICATION; DRUG SAFETY; ECLAMPSIA; FATIGUE; FLUSHING; GESTATIONAL AGE; HEADACHE; HEART PALPITATION; HELLP SYNDROME; HEMOLYSIS; HUMAN; HYPERTENSION ENCEPHALOPATHY; HYPONATREMIA; INCIDENCE; KIDNEY DISEASE; LIVER DYSFUNCTION; MATERNAL HYPERTENSION; MATERNAL WELFARE; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; METHEMOGLOBINEMIA; NONHUMAN; PREECLAMPSIA; PREGNANCY; PRENATAL CARE; PRIORITY JOURNAL; REVIEW; SCREENING TEST; SIDE EFFECT; SKIN TINGLING; SOMNOLENCE; SYMPTOMATOLOGY; TACHYCARDIA; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREMOR; UNITED STATES; URIC ACID BLOOD LEVEL; WELLBEING; XEROSTOMIA;

ADULT; ANTIHYPERTENSIVE AGENTS; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; FETUS; HUMANS; HYPERTENSION; HYPERTENSIVE ENCEPHALOPATHY; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR;

EID: 14844292547     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612053381864     Document Type: Review

References (60)

1. Report of the National High Blood Pressure Education Program. Working group report on high blood pressure in pregnancy. Am J Obstet Gynecol 2000; 183: S1-S
2. Sibai BM. Diagnosis and management of chronic hypertension in pregnancy. Obstet Gynecol 1991; 78: 451-461.
3. Chesley LC. Hypertension and renal disease. In Chesley LC (ed): Hypertensive disorders in pregnancy, ed New York, Appleton-Century-Crofts. 1978; 478-485.
4. Sibai BM, Abdella TN, Anderson GD. Pregnancy outcome in 211 patients with mild chronic hypertension. Obstet Gynecol 1983; 61: 571-576.
5. Sibai BM. Chronic hypertension in pregnancy. Clin Perinatol 1991; 18: 833-844.
6. Rubin PC. Current concepts: beta-blockers in pregnancy. N Engl J Med 1981; 305: 1323-1326.
7. Hou SH, Grossman SD, Madias NE. Pregnancy in women with renal disease and moderate renal insufficiency. Am J Med 1985; 78:185-94.
8. Hokegard KH, Karlsson K, Kjellmer I, Rosen KG. ECG-changes in the fetal lamb during asphyxia in relation to beta-adrenoceptor stimulation and blockade. Acta Physiol Scand 1979; 105: 195-203.
9. Kjellmer I, Dagbjartsson A, Hrbek A, Karlsson K, Rosen KG. Maternal beta-adrenoceptor blockade reduces fetal tolerance to asphyxia. A study in pregnant sheep. Acta Obstet Gynecol Scand Suppl 1984; 118: 75-80.
10. Plouin PF, Breart G, Llado J, Dalle M, Keller ME, Goujon H, et al. A randomized comparison of early with consecutive use of antihypertensive drugs in management of pregnancy induced hypertension. Br J Obstet Gynaecol 1990; 97: 134-141.
11. Leather HM, Humphreys DM, Baker P, Chadd MA. A controlled trial of hypotensive agents in hypertension in pregnancy. Lancet 1968; 2: 488-490.
12. Friedman EA, Neff RK. Hypertension-hypotension in pregnancy. JAMA 1978; 239: 2249-2251.
13. Dommisse J. Phenytoin sodium and magnesium sulphate in the management of eclampsia. Br J Obstet Gynaecol 1990; 97: 104-109.
14. Fidler J, Smith V, Fayers P, De Swiet M. Randomized controlled comparative study of methydopa and oxprenolol in treatment of hypertension in pregnancy. BMJ 1983; 286: 1927-1930.
15. Soothill PW, Ajayi R, Campbell S, Gibbs J, Chandran R, Gibb D, et al. Effects of a fetal surveillance unit on admission of antenatal patients to hospital. BMJ 1991; 303: 269-271.
16. Bott-Kanner G, Hirsch M, Friedman S, et al. Antihypertensive therapy in the management of hypertension in pregnancy: a clinical double-blind study of pindolol. Clinic Exp Hypertens 1992; 11: 207-220.
17. Pickles CJ, Symonds EM, Broughton-Pipkin F. The fetal outcome in a randomized double-blind controlled trial of labetalol versus placebo in pregnancy-induced hypertension. Br J Obstet Gynaecol 1989; 96: 38-43.
18. Fabregues G, Alvarez L, Varas Juri P, Drisaldi S, Cerrato C, Moschettoni C, et al. Effectiveness of atenolol in the treatment of hypertension during pregnancy. Hypertension 1992; 19(suppl II): 129-131.
19. Butters L, Kennedy S, Rubin PC. Atenolol in essential hypertension during pregnancy. BMJ 1990; 301: 587-589.
20. Dunlop JC. Chronic hypertension and perinatal mortality. Proc R Soc Med 1966; 59: 838-841.
21. Lip GY, Beevers M, Churchill D, Shaffer LM, Beevers DG, et al. Effect of atenolol on birth weight. Am J Cardiol 1997; 79: 1436-1438.
22. Montan S, Ingemarsson I, Marsal K, Sjoberg NO. Randomized controlled trial of atenolol and pindolol in human pregnancy: effects on fetal hemodynamics. BMJ 1992; 304: 946-949.
23. Montan S, Liedholm H, Lingman G, Marsal K, Sjoberg NO, Solum T. Fetal and uteroplacental hemodynamics during short-term atenolol treatment of hypertension pregnancy. Br J Obstet Gynaecol 1987; 94: 312-317.
24. Cameron AD, Walker JJ, Mathers AM. The effect of antihypertensive therapy on the Doppler waveform in the maternal and fetal vascular system. In Abstracts of the second international Doppler society meeting. International Doppler Society, Paris, France, 7, 1989.
25. Sibai BM, Gonzalez AR, Mabie WC, Moretti M. A comparison of labetalol plus hospitalization versus hospitalization alone in the management of preeclampsia remote from term. Obstet Gynecol 1987; 70: 323-327.
26. Wichman K, Ryden G, Karlberg BE. A placebo controlled trial of metoprolol in the treatment of hypertension in pregnancy. Scand J Clin Lab Invest 1984; 169: 90-
27. Rubin PC, Butters L, Clark DM, Reynolds B, Sumner DJ, Steedman D, et al. Placebo-controlled trial of atenolol in treatment of pregnancy associated hypertension. Lancet 1983; 1: 431-4
28. Meyer NL, Mercer BM, Friedman SA, Sibai BM. Urinary dipstick protein: a poor predictor of absent or severe proteinuria. Am J Obstet Gynecol 1994; 170: 137-141.
29. Redman CW, Beilin LJ, Bonnar J. Treatment of hypertension in pregnancy with methydopa: blood pressure control and side effects. Br J Obstet Gynaecol 1977; 84: 419-426.
30. Redman CW. Treatment of hypertension in pregnancy. Kidney Int 1980; 18: 267-278.
31. Ducsay CA, Thompson JS, Wu AT, Novy MJ. Effects of calcium entry blocker (nicardipine) tocolysis in rhesus macaques: fetal plasma concentrations and cardiorespiratory changes. Am J Obstet Gynecol 1987; 157: 1482-1486.
32. Parisi VM, Salinas JM, Stockmar EJ. Fetal vascular responses to maternal nicardipine administration in the hypertensive ewe. Am J Obstet Gynecol 1989; 161: 1035-1038.
33. Parisi VM, Salinas JM, Stockmar EJ. Placental vascular responses to nicardipine in the hypertensive ewe. Am J Obstet Gynecol 1989; 161: 1039-1043.
34. Furuhashi N, Tsujiei M, Kimura H, Nagae H, Yajima A. Effects of nifedipine on placental blood flow, placental weight and fetal weight in normotensive and spontaneously hypertensive rats. Gynecol Obstet Invest 1992; 34: 193-196.
35. Ahokas RA, Sibai BM, Mabie WC, Anderson GD. Nifedipine does not adversely affect uteroplacental blood flow in the hypertensive term-pregnant rat. Am J Obstet Gynecol 1988; 159: 1440-1445.
36. Lindow SW, Davies N, Davey DA, Smith JA. The effect of sublingual nifedipine on uteroplacental blood flow in hypertensive pregnancy. Br J Obstet Gynaecol 1988; 95: 1276-1281.
37. Hanretty KP, Whittle MJ, Howie CA, Rubin PC. Effect of nifedipine on Doppler flow velocity waveforms in severe preeclampsia. BMJ 1989; 299: 1205-1206.
38. Mari G, Kirshon B, Moise KJ Jr, Lee W, Cotton DB. Doppler assessment of the fetal and uteroplacental circulation during nifedipine therapy for preterm labor. Am J Obstet Gynecol 1989; 161: 1514-1518.
39. Moretti MM, Fairlie FM, Akl S, Khoury AD, Sibai BM. The effect of nifedipine therapy on fetal and placental Doppler waveforms in preeclampsia remote from term. Am J Obstet Gynecol 1990; 163: 1844-1848.
40. Sibai BM, Barton JR, Akl S, Sarinoglu C, Mercer BM. A randomized prospective comparison of nifedipine and bed rest versus bed rest alone in the management of preeclampsia remote from term. Am J Obstet Gynecol 1992; 167: 879-9
41. Levine RJ, Ewell MG, Hauth JC, Curet LB, Catalano PM, Morris CD, et al. Should the definition of preeclampsia include a rise in diastolic blood pressure of > 15mmHg to a level <90 mmHg in association with proteinuria? Am J Obstet Gynecol 2000; 183: 787-792.
42. Sibai BM, Anderson GD, Spinnato JA, Shaver DC. Plasma volume findings in patients with mild pregnancy-induced hypertension. Am J Obstet Gynecol 1983; 147: 16-19.
43. Sibai BM, Grossman RA, Grossman HG. Effects of diuretics on plasma volume in pregnancies with long term hypertension. Am J Obstet Gynecol 1984; 150: 831-835.
44. Hanssens M, Keirse MJ, Vankelecom F, Van Assehe FA. Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy. Obstet Gynecol 1991; 78: 128-135.
45. Kreft-Jais C, Plouin PF, Tchobroutsky C, Boutroy MJ. Angiotensin-converting enzyme inhibitors during pregnancy: a survey of 22 patients given captopril and 9 given enalapril. Br J Obstet Gynaecol 1988; 95: 420-422.
46. Lumbers ER, Burrell JH, Menzies RI, Stevens AD. The effects of converting enzyme inhibitor (captopril) and angiotensin II on fetal renal function. Br J Pharmacol 1993; 110: 821-827.
47. Rosa FW, Bosco LA, Graham CF, Milstien JB, Dreis M, Creamer J. Neonatal anuria with maternal angiotensin converting enzyme inhibition. Obstet Gynecol 1989; 74: 371-374.
48. Crowther C. Magnesium sulphate versus diazepam in the management of eclampsia: a randomized controlled trial. Br J Obstet Gynaecol 1990; 97: 110-117.
49. Bhalla AK, Dhall GI, Dhall K. A safer and more effective treatment regimen for eclampsia. Aust N Z J Obstet Gynecol 1994; 34: 144-1
50. Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulphate with phenytoin for the prevention of eclampsia. N Engl J Med 1995; 333: 201-205.
51. Whitlin AG, Sibai BM. Magnesium sulphate therapy in Preeclampsia and Eclampsia. Obstet Gynecol 1998; 92: 883-889.
52. The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995; 345: 1455-1463.
53. The Magpie Trial Collaborative Group. Do women with preeclampsia, and their babies, benefit from magnesium sulfate? The Magpie trial: A randomized placebo-controlled trial. Lancet 2002; 359: 1877-1890.
54. Prisant LM, Carr AA, Hawkins DW. Treating Hypertensive Emergencies. Controlled reduction of blood pressure and protection of target organs. Postgrad Med 1993; 93: 92-96.
55. Meese RB, Ram CV. Hypertensive cardiovascular emergencies. Compr Ther 1989; 11: 28-38.
56. Barton JR, Sibai BM. Acute life threatening emergencies in Preeclampsia - eclampsia. Clin Obstet Gynecol 1992; 35: 402-413.
57. Gifford R Jr. Management of hypertensive crisis. JAMA 1991; 266: 829-835.
58. Afifi Y, Churchill D. Pharmacological treatment of hypertension in pregnancy. Curr Pharm Design 2003; 9(21): 1745-53.
59. Amudha K, Wong LP, Choy AM, Lang CC. Ethnicity and drug therapy for hypertension. Curr Pharm Design 2003; 9(21): 1691-701.
60. Garcia EA, Newhouse S, Caulfield MJ, Munroe PB. Genes and hypertension. Curr Pharm Design 2003; 9(21): 1679-89.